As A-share trading comes to an end in 2025, the overall situation of brokerage research covering listed companies is also gradually becoming clear. According to Wind data, as of publication on December 30, more than 2,800 A-share listed companies have received brokerage research since 2025, which means that more than half of the listed companies in the market have received brokers' attention; judging from the industry distribution, the three major sectors of machinery, equipment, electronics, pharmaceutics and biology have received the most attention, and more than 290 listed companies have received brokerage surveys within the sector. Regarding investment opportunities in the aforementioned sector in 2026, industry insiders said that the direction of machinery and equipment is optimistic about investment opportunities in the humanoid robot-related industry chain; the electronics industry suggests laying out new technologies, new demands, and new tracks around the AI innovation cycle to develop a high-quality track; and the pharmaceutical and biological industry continues to be optimistic about investment opportunities in the innovative drug industry chain.

As A-share trading comes to an end in 2025, the overall situation of brokerage research covering listed companies is also gradually becoming clear. According to Wind data, as of publication on December 30, more than 2,800 A-share listed companies have received brokerage research since 2025, which means that more than half of the listed companies in the market have received brokers' attention; judging from the industry distribution, the three major sectors of machinery, equipment, electronics, pharmaceutics and biology have received the most attention, and more than 290 listed companies have received brokerage surveys within the sector. Regarding investment opportunities in the aforementioned sector in 2026, industry insiders said that the direction of machinery and equipment is optimistic about investment opportunities in the humanoid robot-related industry chain; the electronics industry suggests laying out new technologies, new demands, and new tracks around the AI innovation cycle to develop a high-quality track; and the pharmaceutical and biological industry continues to be optimistic about investment opportunities in the innovative drug industry chain.